UK markets closed
NIKKEI 225
38,274.05 -131.61 (-0.34%) HANG SENG
17,763.03 +16.12 (+0.09%) CRUDE OIL
79.11 -2.82 (-3.44%) GOLD FUTURES
2,325.70 +22.80 (+0.99%) DOW
37,903.29 +87.37 (+0.23%) Bitcoin GBP
45,605.52 -1,757.08 (-3.71%)
Neurocrine Biosciences, Inc. (NBIX)
NasdaqGS - NasdaqGS Real-time price. Currency in USD
Add to watchlist
At close: 04:00PM EDT
After hours:
Currency in USD
Valuation measures4
| Market cap (intra-day) | 13.83B |
| Enterprise value | 13.22B |
| Trailing P/E | 55.66 |
| Forward P/E | 26.67 |
| PEG ratio (5-yr expected) | 0.45 |
| Price/sales (ttm) | 7.36 |
| Price/book (mrq) | 6.20 |
| Enterprise value/revenue | 7.01 |
| Enterprise value/EBITDA | 36.94 |
Trading information
Stock price history
| Beta (5Y monthly) | 0.28 |
| 52-week change 3 | 39.46% |
| S&P500 52-week change 3 | 23.10% |
| 52-week high 3 | 148.37 |
| 52-week low 3 | 89.04 |
| 50-day moving average 3 | 136.76 |
| 200-day moving average 3 | 121.81 |
Share statistics
| Avg vol (3-month) 3 | 888.57k |
| Avg vol (10-day) 3 | 791.79k |
| Shares outstanding 5 | 100.58M |
| Implied shares outstanding 6 | 100.58M |
| Float 8 | 98.29M |
| % held by insiders 1 | 1.00% |
| % held by institutions 1 | 94.72% |
| Shares short (15 Apr 2024) 4 | 2.02M |
| Short ratio (15 Apr 2024) 4 | 2.26 |
| Short % of float (15 Apr 2024) 4 | 2.35% |
| Short % of shares outstanding (15 Apr 2024) 4 | 2.01% |
| Shares short (prior month 15 Mar 2024) 4 | 2.48M |
Dividends & splits
| Forward annual dividend rate 4 | N/A |
| Forward annual dividend yield 4 | N/A |
| Trailing annual dividend rate 3 | 0.00 |
| Trailing annual dividend yield 3 | 0.00% |
| 5-year average dividend yield 4 | N/A |
| Payout ratio 4 | 0.00% |
| Dividend date 3 | N/A |
| Ex-dividend date 4 | 29 Dec 1995 |
| Last split factor 2 | N/A |
| Last split date 3 | N/A |
Financial highlights
Fiscal year
| Fiscal year ends | 31 Dec 2023 |
| Most-recent quarter (mrq) | 31 Dec 2023 |
Profitability
| Profit margin | 13.23% |
| Operating margin (ttm) | 29.17% |
Management effectiveness
| Return on assets (ttm) | 8.78% |
| Return on equity (ttm) | 12.68% |
Income statement
| Revenue (ttm) | 1.89B |
| Revenue per share (ttm) | 19.32 |
| Quarterly revenue growth (yoy) | 25.00% |
| Gross profit (ttm) | N/A |
| EBITDA | 416.1M |
| Net income avi to common (ttm) | 249.7M |
| Diluted EPS (ttm) | 2.47 |
| Quarterly earnings growth (yoy) | 66.00% |
Balance sheet
| Total cash (mrq) | 1.03B |
| Total cash per share (mrq) | 10.37 |
| Total debt (mrq) | 460.4M |
| Total debt/equity (mrq) | 20.63% |
| Current ratio (mrq) | 2.45 |
| Book value per share (mrq) | 22.61 |
Cash flow statement
| Operating cash flow (ttm) | 389.9M |
| Levered free cash flow (ttm) | 405.08M |
© 2024 Yahoo. All rights reserved.